This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.



  • New Tuberculosis Test More Than Skin Deep
    A new screening process for tuberculosis (TB) infections in Canadian prisons could mean that more than 50 percent of those screened won't undergo unnecessary treatment due to false positives. According to research by Wendy Wobeser and medical resident Ilan Schwartz, a test ...More
    June 6, 2014 Posted in News
  • Shorter TB Treatment Regimens Will Reduce Costs for Patients
    Shorter TB treatment regimens will reduce the out-of-pocket expenses incurred by both patients and their family members, who often act as the patients' guardians. In addition, shorter TB regimens may allow an earlier return to productive activities for patients and their ...More
    June 5, 2014 Posted in News
  • TB Lung Infection Causes Changes in the Diversity of Gut Bacteria
    Johns Hopkins researchers have found evidence in mice that a tuberculosis (TB) infection in the lungs triggers immune system signaling to the gut that temporarily decreases the diversity of bacteria in that part of the digestive tract. The researchers showed that this ...More
    May 14, 2014 Posted in News
  • Multi-Target TB Drug Could Treat Other Diseases, Evade Resistance
    A drug under clinical trials to treat tuberculosis could be the basis for a class of broad-spectrum drugs that act against various bacteria, fungal infections and parasites, yet evade resistance, according to a study by University of Illinois chemists and collaborators. ...More
    April 18, 2014 Posted in News
  • New TB Screening Guidelines Overseas Save U.S. Estimated $15 Million
    Updated Centers for Disease Control and Prevention (CDC) recommendations for overseas tuberculosis (TB) screening of immigrants and refugees have identified hundreds of cases that otherwise would have gone undetected until after arrival in the United States, saving ...More
    March 20, 2014 Posted in News
  • Progress in Diagnosing Multidrug-Resistant Tuberculosis
    Almost half a million people fell ill with multidrug-resistant tuberculosis (MDR-TB) in 2012, yet less than 1 in 4 of these people was diagnosed, mainly due to a lack of access to quality diagnostic services. But with an innovative international project, 27 countries are ...More
    March 20, 2014 Posted in News
  • CDC Offers Public Health Grand Rounds on Drug-Resistant TB
    The Centers for Disease Control and Prevention (CDC) will offer the Public Health Grand Rounds session, “Multidrug-Resistant Tuberculosis: New Tools to Tackle New Challenges from an Old Foe,” on March 18, at 1 p.m. EDT. Tuberculosis is an ancient disease ...More
    March 11, 2014 Posted in News
  • Vitamin A May Help Boost Immune System to Fight Tuberculosis
    In findings published in the March 1 issue of the Journal of Immunology, UCLA researchers investigating the role of nutrients in helping the immune system fight against major infections show that vitamin A may play an important role combating tuberculosis (TB). The UCLA ...More
    February 25, 2014 Posted in News
  • Vinegar Kills Tuberculosis and Other Mycobacteria
    The active ingredient in vinegar, acetic acid, can effectively kill mycobacteria, even highly drug-resistant Mycobacterium tuberculosis, an international team of researchers from Venezuela, France, and the U.S. reports in mBio®, the online open-access journal of the ...More
    February 25, 2014 Posted in News
  • NIH Scientists Develop Way to Make Old Antibiotic Work Against TB
    Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have developed a method to synthesize modified forms of an established antibiotic called spectinomycin. The modified forms, unlike the ...More
    January 27, 2014 Posted in News